Panel orders Soliris price cut but rejects CLHIA bid to reimburse private payers
While a Patented Medicine Prices Review Board hearing panel has ordered Alexion Pharmaceuticals Inc. to lower the price of the drug Soliris, it has rejected…
- By: Glenn Kauth
- October 2, 2017 September 13, 2019
- 08:47